HomeGPCR • NASDAQ
Structure Therapeutics Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 56.31M | 75.89% |
Net income | -46.83M | -79.88% |
Net profit margin | — | — |
Earnings per share | -0.27 | -42.11% |
EBITDA | -56.04M | -76.26% |
Effective tax rate | -0.21% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 836.88M | 91.75% |
Total assets | 866.55M | 89.52% |
Total liabilities | 41.91M | 52.92% |
Total equity | 824.64M | — |
Shares outstanding | 57.54M | — |
Price to book | 1.70 | — |
Return on assets | -15.91% | — |
Return on capital | -16.55% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -46.83M | -79.88% |
Cash from operations | -52.23M | -53.25% |
Cash from investing | 34.03M | 2,300.07% |
Cash from financing | 809.00K | 15.24% |
Net change in cash | -17.39M | 45.60% |
Free cash flow | -40.59M | -61.41% |
Previous close
$24.43
Year range
$13.22 - $62.74
Market cap
1.41B USD
Avg Volume
1.09M
Primary exchange
NASDAQ
About
Founded
2016
Headquarters
Website
Employees
183
